The mitochondrial genome as a modifier of autism versus cancer phenotypes in <i>PTEN</i> hamartoma tumor syndrome.

HGG Adv · 2023 · PMC10193119 · PMID 37216009

Europe PMC DOI

hedged sentence

0.0860

closest p · 1.7× alpha

0.0860

boldest claim

The sentences

showed a trendp = 8.6 × 10 −2so close (0.05 < p ≤ 0.1)

After controlling for age at consent, the onlyASD/DD group still showed a trend toward higher burden of mtDNA CN compared with the onlyCancer group (p = 8.6 × 10 −2 ) ( Figure 2 A and Tables S1 and S2 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.